Ferric Derisomaltose Injection — Competitive Intelligence Brief

Ferric Derisomaltose Injection (Ferric Derisomaltose Injection) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron replacement agent. Area: Hematology.

phase 3 Iron replacement agent Iron metabolism pathway Hematology Small molecule

Target snapshot

Ferric Derisomaltose Injection (Ferric Derisomaltose Injection) — Hallym University Medical Center. Ferric derisomaltose is an iron replacement therapy that delivers ferric iron complexed with derisomaltose to replenish depleted iron stores.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Ferric Derisomaltose Injection TARGET	Ferric Derisomaltose Injection	Hallym University Medical Center	phase 3	Iron replacement agent	Iron metabolism pathway
Ferric Carboxymaltose Injection	Ferric Carboxymaltose Injection	Sichuan Huiyu Pharmaceutical Co., Ltd	marketed	Iron replacement agent	Iron metabolism pathway; transferrin receptor
Iron isomaltoside/ferric derisomaltose	Iron isomaltoside/ferric derisomaltose	Pharmacosmos A/S	phase 3	Iron replacement therapy	Iron metabolism pathway; ferric iron (Fe3+)
High-dose ferric derisomaltose	High-dose ferric derisomaltose	China-Japan Friendship Hospital	marketed	Iron replacement agent
Iron Carboxymaltose	Iron Carboxymaltose	Albina Nowak, MD	marketed	Intravenous iron replacement agent	Iron(III) ion; transferrin and ferritin (iron-binding proteins)
Intravenous iron sucrose	Intravenous iron sucrose	Ain Shams University	marketed	Iron replacement agent
intravenous iron carboxymaltose	intravenous iron carboxymaltose	University of Zurich	marketed	Intravenous iron replacement agent	Iron (Fe³⁺) delivery system; transferrin receptor-mediated uptake

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron replacement agent class)

1. University of Maryland, Baltimore · 2 drugs in this class
2. Ain Shams University · 1 drug in this class
3. American Regent, Inc. · 1 drug in this class
4. Azad Pharma AG · 1 drug in this class
5. CN NGANOU-GNINDJIO, MD, MSc · 1 drug in this class
6. China-Japan Friendship Hospital · 1 drug in this class
7. Hallym University Medical Center · 1 drug in this class
8. J. Uriach and Company · 1 drug in this class
9. JW Pharmaceutical · 1 drug in this class
10. Prince of Wales Hospital, Shatin, Hong Kong · 1 drug in this class